Sharper Insights. Smarter Decisions.
DovaVision™ uses advanced artificial intelligence (AI) to automate scoring and rapidly analyze the severity of ulcerative colitis (UC) from endoscopy videos. Designed for research and clinical trials, it ensures enriched, consistent, objective, and efficient evaluation of UC clinical trial endoscopy video data. The Dova solution offers a dynamic frame-level Mayo Endoscopic Subscore (MES) analysis providing adjunct AI reads for Phase I through IV IBD clinical trials.
DovaVision™ is powered by Dova Health Intelligence™
(Previously Satisfai Health)
Powered for Precision
Dova’s AI technology was designed and built for purpose using a comprehensive global dataset of anonymized IBD colonoscopy videos, integrating data annotation and clinical insights from Alimentiv’s global leading expert readers on IBD disease assessment and scoring within clinical trials.
DovaVision™ Provides:
Dynamic Frame-Level Analysis
- Generate dynamic severity assessments across the full procedure; available as raw data for further analysis with intuitive visual outputs.
Granular Disease Evaluation
- Quantify subtle variations in inflammation, ulceration, and other disease markers across different regions of the colon.
Deep Feature Mapping
- Analyze disease features that drive scoring decisions, ensuring precision and transparency of disease grading.
Reliable AI for Smarter Clinical Trials
- Detect nuanced changes in disease activity: Reveal subtle patterns and changes in disease activity that may be missed by the human eye; these insights empower better decision-making in both clinical development and postmarketing strategies
- Proactively ensure data quality and consistency: DovaVision™ automatically flags low-quality to enable earlier issue trending and mitigation across sites to reduce costly post-study corrections; this proactive oversight ensures data integrity from day one
- Scale without increasing manual workload: Seamlessly integrate automated video analysis into clinical trial workflows; DovaVision™ operates in parallel with trial procedures, minimizing human burden and enabling smooth deployment across global, multicenter studies
- Standardized, deterministic scoring you can trust: DovaVision™ provides consistent AI-powered assessments — ensuring the same result for the same input, every time; this supports reliable, trial-wide data integrity
